Calamos Advisors
MGNX icon

Calamos Advisors’s MacroGenics MGNX Stock Holding History

Calamos Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-22,850
Closed -$636K – 652
2014
Q1 		$636K Sell
22,850
-2,150
-9% -$75.9K ﹤0.01% 564
2013
Q4 		$686K Buy
+25,000
New +$654K ﹤0.01% 560

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
PCA
Private Capital Advisors Darien, Connecticut $872M AUM 26.12% 1-Year Est. Return

Calamos Advisors's MGNX Position: Q2 2014 in Review

Calamos Advisors sold out of MacroGenics (MGNX) in Q2 2014, closing a stake of 22,850 shares — an estimated $636K sold.

Calamos Advisors first reported a position in MGNX in Q4 2013 and held it in 2 quarters. The position peaked at $686K in Q4 2013. 89 funds tracked by Wall St. Rank hold MGNX as of Q2 2014.

  • Calamos Advisors reported no remaining MacroGenics position as of Q2 2014 after selling out during the quarter.
  • Calamos Advisors sold 22,850 MacroGenics shares in Q2 2014, an estimated $636K.
  • Calamos Advisors first reported a position in MacroGenics in Q4 2013 and held it in 2 quarters.
  • Calamos Advisors's MacroGenics position peaked at $686K in Q4 2013.
  • 89 funds tracked by Wall St. Rank held MacroGenics as of Q2 2014.

Based on Calamos Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.